C12N 2770/10022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/10022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 111 US grants and 135 published applications in this corpus.
Search patents in C12N- Granted patents
- 111
- Published applications
- 135
- Assignees
- 71
- Inventors
- 231
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 1 |
| 2002 | 4 | 3 |
| 2003 | 5 | 13 |
| 2004 | 2 | 8 |
| 2005 | 2 | 5 |
| 2006 | 5 | 7 |
| 2007 | 6 | 7 |
| 2008 | 3 | 10 |
| 2009 | 8 | 9 |
| 2010 | 5 | 9 |
| 2011 | 2 | 7 |
| 2012 | 6 | 7 |
| 2013 | 5 | 6 |
| 2014 | 11 | 9 |
| 2015 | 4 | 4 |
| 2016 | 3 | 7 |
| 2017 | 7 | 5 |
| 2018 | 5 | 2 |
| 2019 | 2 | 2 |
| 2020 | 3 | 7 |
| 2021 | 3 | 0 |
| 2022 | 4 | 2 |
| 2023 | 0 | 1 |
| 2024 | 2 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N protein epitope mutation marker for preparing epitope deletion-marked vaccine strain of type II porcine reproductive and respiratory syndrome virus (PRRSV) and use thereof19 May 2026US 12,629,411 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Recombinant antigen and method of making the same, isolated polynucleotide of porcine reproductive and respiratory syndrome virus (PRRSV) and immunogenic composition including the same12 Aug 2025US 12,383,613 B2National Pingtung University of Science and Technology
- Chimeric molecules and uses thereof15 Oct 2024US 12,116,386 B2The University of Queensland
- North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof20 Feb 2024US 11,904,011 B2Zoetis Services LLC
- Bacillus based delivery system and methods of use2 Aug 2022US 11,401,498 B2The Curators of the University of Missouri
- Epitope and immunogen design for development of vaccines, diagnostics, and immunotherapeutics6 Nov 2025US 2025/0342906 A1Iowa State University Research Foundation, Inc.
- Chimeric virus expressing porcine productive and respiratory syndrome virus-derived peptide and vaccine composition comprising same17 Apr 2025US 2025/0121047 A1Biopoa, Inc.
- Self-amplifying messenger rna12 Sep 2024US 2024/0301006 A1Glaxosmithkline Biologicals SA
- N protein epitope mutation marker for preparing epitope deletion-marked vaccine strain of type ii porcine reproductive and respiratory syndrome virus (prrsv) and use thereof9 May 2024US 2024/0148850 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Recombinant antigen and method of making the same, isolated polynucleotide of porcine reproductive and respiratory syndrome virus (prrsv) and immunogenic composition including the same9 Mar 2023US 2023/0074637 A1National Pingtung University of Science and Technology
Most cited
By later US patents
- Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome71US 5,695,766 AIowa State University Research Foundation, Inc. · 1997
- Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits63US 5,620,691 AStichting Centraal Diergeneeskundig Instituut · 1997
- Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins63US 5,888,513 ACyanamid Iberica, S.A. · 1999
- Fusion antigen used as vaccine63US 7,335,361 B2Animal Technology Institute Taiwan · 2008
- Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof55US 6,841,364 B2ProtaTek International, Inc. · 2005